IV 
119TH CONGRESS 
1ST SESSION 
H. RES. 392 
Expressing support for the designation of May as ‘‘National Bladder Cancer 
Awareness Month’’. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 6, 2025 
Mr. MURPHY (for himself, Mr. DAVIS of North Carolina, Mr. FITZPATRICK, 
Mr. TONKO, Mr. DAVID SCOTT of Georgia, Ms. SEWELL, Ms. BARRAGA´N, 
Mr. ADERHOLT, Ms. NORTON, and Mr. CONNOLLY) submitted the fol-
lowing resolution; which was referred to the Committee on Energy and 
Commerce 
RESOLUTION 
Expressing support for the designation of May as ‘‘National 
Bladder Cancer Awareness Month’’. 
Whereas increased public awareness and early treatment of 
bladder cancer will save thousands of lives; 
Whereas more than 800,000 families in the United States 
live with bladder cancer; 
Whereas it is estimated that more than 84,870 people in the 
United States, or over 230 Americans every day, will be 
diagnosed with bladder cancer in 2025, including over 
65,080 men and 19,790 women; 
Whereas it is estimated that bladder cancer will kill more 
than 17,420 Americans this year alone; 
VerDate Sep 11 2014 
22:18 May 06, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR392.IH
HR392
ssavage on LAPJG3WLY3PROD with BILLS
•HRES 392 IH 
Whereas bladder cancer can directly impact all people, re-
gardless of age, sex, and race; 
Whereas bladder cancer is among the top 7 most diagnosed 
cancers in the United States, and the top 4 most com-
monly diagnosed cancers for our honored veterans; 
Whereas, if diagnosed early, bladder cancer is highly treat-
able, but survivability rates decrease substantially with 
later detection; 
Whereas smoking and environmental or occupational expo-
sure to carcinomic chemicals are the top causes of blad-
der cancer; 
Whereas studies have shown a higher level of bladder cancer 
in firefighters, veterans, and senior citizens than in the 
general public; 
Whereas bladder cancer symptoms, such as blood in the 
urine, are easily recognized, however, many Americans 
are unaware of the warning signs and often put off diag-
nostic testing and treatment; 
Whereas bladder cancer is known as one of the most expen-
sive cancers to treat on a per patient basis and has a re-
occurrence rate of approximately 50 to 80 percent, re-
quiring lifelong surveillance; 
Whereas, while bladder cancer is more prevalent in men, 
women are commonly diagnosed at a later stage and face 
a worse prognosis even when diagnosed at the same stage 
as men; 
Whereas there have been limited significant breakthroughs in 
the past 30 years to advance the treatment of and move 
toward a cure for bladder cancer; 
VerDate Sep 11 2014 
22:18 May 06, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR392.IH
HR392
ssavage on LAPJG3WLY3PROD with BILLS
•HRES 392 IH 
Whereas the quality of life and chance of survival for a blad-
der cancer patient depends largely on new advancements 
and a renewed focus on research from both the Federal 
Government and private industry; 
Whereas increased awareness for bladder cancer will promote 
earlier diagnosis and increased chances of survival; 
Whereas, in 2025, Congress will require the Department of 
Veterans Affairs to dramatically increase bladder cancer 
treatments for the Nation’s veterans exposed to toxins 
from burn pits under the Honoring our PACT Act of 
2022, living up to the promise the Nation made decades 
ago; 
Whereas based on the Nation’s experience diagnosing and 
caring for Vietnam veterans exposed to carcinogenic 
chemicals such as Agent Orange and Agent Blue; 
Whereas the Congressionally Directed Medical Research Pro-
grams, working concurrently with the National Institutes 
of Health, annually fund the high-risk, high-reward re-
search required to one day discover a cure for bladder 
cancer; 
Whereas traditionally throughout May, survivors, caregivers, 
and loved ones unite for walks in communities across the 
United States to raise awareness for bladder cancer along 
with funds for bladder cancer research; 
Whereas the Bladder Cancer Advocacy Network has worked 
for 20 years to raise public awareness for bladder cancer 
while providing patients with the knowledge, resources, 
and support they need to navigate their personal bladder 
cancer journey; 
Whereas the Bladder Cancer Advocacy Network annually 
funds cutting edge research in search of better treat-
VerDate Sep 11 2014 
22:18 May 06, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\HR392.IH
HR392
ssavage on LAPJG3WLY3PROD with BILLS
•HRES 392 IH 
ments and a final cure for bladder cancer while working 
every day to raise public awareness, support patients, and 
increase research; and 
Whereas May would be an appropriate month to designate as 
‘‘National Bladder Cancer Awareness Month’’: Now, 
therefore, be it 
Resolved, That the House of Representatives— 
(1) supports the designation of ‘‘National Blad-
der Cancer Awareness Month’’; 
(2) supports the goals and ideals of ‘‘National 
Bladder Cancer Awareness Month’’; and 
(3) calls on the people of the United States, in-
terested groups, the research community, and af-
fected persons to— 
(A) promote awareness of bladder cancer 
and foster understanding of the impact of the 
disease on patients, their families, caregivers, 
and their community; 
(B) take an active role in the fight to end 
bladder cancer; and 
(C) observe ‘‘National Bladder Cancer 
Awareness Month’’ with appropriate ceremonies 
and activities. 
Æ 
VerDate Sep 11 2014 
22:18 May 06, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HR392.IH
HR392
ssavage on LAPJG3WLY3PROD with BILLS